Disease and Therapy Review: Lung Cancer

Timely Data Resources, Inc, November 2012, Pages: 15

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities.

Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

The Lung Cancer Disease and Therapy Review provides an overview of small cell and non-small cell lung cancer, with incidence, prevalence, and mortality numbers for major countries worldwide, information on diagnosis, and an overview of treatment. General information on the lung cancer market, as well as sales of leading drugs and therapies are provided.

I. OVERVIEW
General description of the condition
Risk factors
SCLC description, staging and survival rates
NSCLC description, staging and survival rates

II. INCIDENCE, PREVALENCE AND MORTALITY
Incidence Table (Canada, U.S., Argentina, Brazil, Mexico, France, Germany, Greece, Italy, Poland, Russian Federation, Spain, Turkey, UK, China, India, Japan, Philippines, Thailand, Egypt, South Africa, Africa, Americas, Eastern Mediterranean, Europe, Southeast Asia, Western Pacific, Worldwide)
Prevalence Table (Canada, U.S., Argentina, Brazil, Mexico, France, Germany, Greece, Italy, Poland, Russian Federation, Spain, Sweden, Turkey, UK, China, India, Japan, Korea, Philippines, Thailand, Egypt, South Africa, Africa, Americas. Eastern Mediterranean, Europe, Southeast Asia, Western Pacific, More Developed, Less Developed, Worldwide)

Mortality Table (Canada, U.S., Argentina, Brazil, Mexico, France, Germany, Greece, Italy, Poland, Russian Federation, Spain, Turkey, UK, China, India, Japan, Philippines, Thailand, Egypt, South Africa, Australia, Africa, Americas, Eastern Mediterranean, Europe, European Union, Southeast Asia, Western Pacific, Worldwide)

III. DIAGNOSIS
Symptoms and signs
Diagnostic tools and procedure

IV. TREAMENT
SCLC treatment
NSCLC treatment, including treatment options by stage and chemotherapy

V. MARKET SIZE
Market overview
Sales information for key pharmaceuticals

VI. COMMENTS

VII. REFERENCES/RESOURCES

Customers who bought this item also bought

• Global Biosimilars Market - Products, Applications and Regulations
• Global Pancreatic Cancer Epidemiology and Patient Flow Analysis - 2012
• Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity
• Disease and Therapy Review: Epilepsy
• Disease and Therapy Review: Diabetes
• Global Type 1 Diabetes Epidemiology and Patient Flow Analysis - 2012
• Global Prostate Cancer Epidemiology and Patient Flow Analysis - 2012
• Global Diabetic Retinopathy Epidemiology and Patient Flow Analysis - 2012
• Global Overactive Bladder Epidemiology and Patient Flow Analysis - 2012
• Global Ulcerative Colitis Epidemiology and Patient Flow Analysis - 2012